Sensei Biotherapeutics, Inc. (SNSE)
USD 0.43
(-11.1%)
USD 0.43
(-11.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 571 Thousand | 1.8 Million | 685 Thousand | 209 Thousand | 73 Thousand | 44 Thousand |
| Gross Profit | -571 Thousand | -1.8 Million | -685 Thousand | -209 Thousand | -73 Thousand | -44 Thousand |
| Operating Expenses | 37.06 Million | 50.18 Million | 37.48 Million | 18.71 Million | 12.43 Million | 12.74 Million |
| Selling, General and Administrative Expenses | 18.66 Million | 19.8 Million | 15.82 Million | 7.52 Million | 4.08 Million | 4.51 Million |
| Research and Development Expenses | 18.29 Million | 30.38 Million | 21.66 Million | 11.18 Million | 8.35 Million | 8.22 Million |
| Other Expenses | - | 1.6 Million | 688 Thousand | -649 Thousand | -1000.00 | 28 Thousand |
| Cost and Expenses | 37.06 Million | 50.18 Million | 37.48 Million | 18.71 Million | 12.43 Million | 12.74 Million |
| Operating Income | -37.06 Million | -50.18 Million | -37.48 Million | -19.45 Million | -12.43 Million | -12.74 Million |
| Interest Expense | 144 Thousand | 219 Thousand | 670 Thousand | 1.68 Million | 2.25 Million | 327 Thousand |
| Income Tax Expense | - | 219 Thousand | 670 Thousand | 529 Thousand | 2.25 Million | 299 Thousand |
| Earnings before Tax | -34.1 Million | -48.58 Million | -36.79 Million | -20.1 Million | -16.74 Million | -13.03 Million |
| Net Income | -34.1 Million | -48.8 Million | -37.46 Million | -20.62 Million | -18.99 Million | -13.03 Million |
| Earnings Per Share Basic | -1.22 | -1.59 | -1.35 | -0.67 | -0.65 | -19.03 |
| Earnings Per Share Diluted | -1.22 | -1.59 | -1.35 | -0.67 | -0.65 | -19.03 |
| Weighted Average Shares Outstanding | 27.95 Million | 30.7 Million | 27.71 Million | 30.58 Million | 29.32 Million | 685.16 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 27.95 Million | 30.7 Million | 27.71 Million | 30.58 Million | 29.32 Million | 685.16 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -33.38 Million | -46.56 Million | -36.79 Million | -18.5 Million | -12.36 Million | -12.69 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 2.84 Million | - | - |
| Cost of Revenue | 135 Thousand | 137 Thousand | 571 Thousand | 135 Thousand | 455 Thousand | 491 Thousand |
| Gross Profit | -135 Thousand | -137 Thousand | -571 Thousand | 2.71 Million | -455 Thousand | -491 Thousand |
| Operating Expenses | 7.65 Million | 8.59 Million | 36.49 Million | 8 Million | 7.73 Million | 10.17 Million |
| Selling, General and Administrative Expenses | 3.06 Million | 3.67 Million | - | 3.51 Million | 3.91 Million | 5.39 Million |
| Research and Development Expenses | 4.58 Million | 4.91 Million | - | 4.49 Million | 3.81 Million | 4.78 Million |
| Other Expenses | - | -2000.00 | - | -67 Thousand | 613 Thousand | 68 Thousand |
| Cost and Expenses | 7.78 Million | 8.73 Million | 37.06 Million | 8.14 Million | 7.73 Million | 10.17 Million |
| Operating Income | -7.78 Million | -8.73 Million | -37.06 Million | -8.14 Million | -7.73 Million | -10.17 Million |
| Interest Expense | 24 Thousand | 28 Thousand | 144 Thousand | 31 Thousand | 33 Thousand | 38 Thousand |
| Income Tax Expense | - | 93.72 Thousand | - | 1.45 Million | -332 Thousand | 106 Thousand |
| Earnings before Tax | -7.14 Million | -7.99 Million | -34.1 Million | -7.41 Million | -7.12 Million | -9.38 Million |
| Net Income | -7.14 Million | -7.99 Million | -34.1 Million | -7.41 Million | -7.12 Million | -9.38 Million |
| Earnings Per Share Basic | -0.28 | -0.32 | - | -0.30 | -0.28 | -0.31 |
| Earnings Per Share Diluted | -0.28 | -0.32 | - | -0.30 | -0.28 | -0.31 |
| Weighted Average Shares Outstanding | 25.1 Million | 25.04 Million | 27.95 Million | 25.03 Million | 25.51 Million | 30.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.1 Million | 25.04 Million | 27.95 Million | 25.03 Million | 25.51 Million | 30.5 Million |
| Gross Margin | - | - | - | 0.95 | - | - |
| EBIT Margin | - | - | - | -2.81 | - | - |
| Profit Margin | - | - | - | -2.61 | - | - |
| EBITDA | -7.65 Million | -8.59 Million | - | -8 Million | -7.73 Million | -8.82 Million |
| Earnings Before Tax Margin | - | - | - | -2.86 | - | - |
CVNA
WORL
COFORGE
TGII
SMARTLINK
MBINO